Call (866) 282-9695. http://nwbio.com/wp-content/uploads/ASCO-2019-Presentation-FINAL.pdf. The most important statement that, Probably the way the laws are written NWBO, There is no new information about the clinical, I should have been clearer, I believe right, Potential buyers can have a look/review of trial, I still don't believe buyout would happen before. NWBO Stock Message Board for Investors. In that scenario, nwbo is unlikely to have the few million in cash, so Advent agrees to accept Flaskworks and Sawston lease benefits instead. His website offers a good deal more analysis. NWBO gets $11M loan rather than sell shares at low price, they must know they are going to go up significantly. You're welcome!!! - Larry Smith, July 1, 2019 Part 9:  Illegal Naked Shorting:  The Risk/Reward of Shorting Versus Buying Stocks is Extremely Unfavorable - Larry Smith, July 11, 2019 Part 10:  Illegal Naked Shorting:  Legal Shorting of Stocks is a Loser Game But Illegal Naked Shorting Transforms It Into a Winner's Game - Larry Smith, July 24, 2019 Transfer Agent  Computershare Trust Company, N.A. NWBO Facebook NWBO Yahoo Message Board Upcoming Healthcare Conferences Institutional Investments Nearing "the finish line" on cancer vaccine trial, Maryland firm raises $40 million - April 3, 2015 (J.D. (see minute 19:10), Brain Cancer Vaccine Moves Closer to Reality During Clinical Trial, New Vaccine for Aggressive Brain Cancer Shows Promising Results, Personalized vaccine may increase long-term survival in people with the deadliest form of brain cancer, New approach to treating glioblastoma could add years to patients' lives, Personalized Vaccine Effective in Some Glioblastoma Patients, Brain Cancer Vaccine Could Boost Incurable Glioblastoma Survival from Months to Years, Scientists created a brain-cancer vaccine - and so far it's 'remarkably promising', Outcomes of immunotherapy vaccine trial show encouraging results for glioblastoma patients, Brain cancer vaccine could give years of extra life to patients like Dame Tessa Jowelll, finds trial, Brain cancer could extend lives of patients by years - Belfast Telegraph, Vaccine for cancer that killed Tessa Jowell 'remarkably promising', Brain cancer vaccine could extend lives of patients by years, Cancer Treatments - Supplement in United Kingdom Times, NW Bio Announces $40 Million Financing - Further Equity by Woodford Funds, Woodford's new biotech could be the next Amgen, Neil Woodford invests £16m in brain cancer vaccine company. Northwest Biotherapeutics Inc stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors Mayo Professor, Chair of Neurologic Sugery, Mayo Clinic in Jacksonville, FL,  Dr. Jerome Galon - French Biologist, Ph.D. in Immunology, Cordeliers Research Center, Director of the INSERM Laboratory Integrative Cancer Immunology Dr. Samir N. Khleif - Director of the GRU Cancer Center, Augusta, GA Dr. John Smyth - Professor Emeritus Medical Oncology and Honorary Assistant Principal Cancer Research Development Scientific Advisory Board PR Announcement: - June 13, 2016 Sawston Location US Biotechnology Company Doses Upon Space in Cambridge - link is to i-hub post with story. The Stock Market Is Trash! - September 1, 2020 Automating Reproducible Dendritic Cell Production - FlaskWorks MicroDen - August 1, 2019 Flaskworks Patent Information Glioblastoma Subtypes source:  Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach - February 2018 United Kingdom Awards DC-Vax-L® as Promising Innovative Medicine (PIM) - FIRST TIME EVER First UK "Promisting Innovative Medicine" Designation Awarded (Department of Health and George Freeman MP, Gov.UK, September 16, 2014) NWBO's Cancer Vaccine is the First Drug to be Designated by UK Authorities as a "Promising Innovative Medicine" (PIM) - (NWBO, September 16, 2014) Interviews Linda Powers Interview 5-15-12 Important or Helpful Links NWBO Stock Quote & Information NWBO SEC Filings NWBO Twitter NWBO Facebook NWBO Yahoo Message Board Upcoming Healthcare Conferences Institutional Investments Nearing "the finish line" on cancer vaccine trial, Maryland firm raises $40 million - April 3, 2015 (J.D. Yes. Good game. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. Harrison) Northwest Biotherapeutics: The $40 Million Woodford Financing is A Major Positive - April 3, 2105 (Smith on Stocks - Larry Smith) The latest rating update was made on Mar. Equity multiplier, or assets relative to shareholders' equity, comes in at -0.12 for Northwest Biotherapeutics Inc; that's greater than it is for just 6.97% of US stocks. Negative blogs have contended that NWBO has included the clinical data from 32 pseudo-progressors in the clinical data base of 331 patients enrolled in the phase They have been saying that for almost 10 years. Northwest Biotherapeutics (QB) (NWBO) stock price, charts, trades & the US's most popular discussion forums. Northwest Biotherapeutics, Inc. OTC Updated Apr 1, 2021 3:42 PM NWBO 1.38 0.11 (7.38%). Box 30170, College Station, Texas  77842 Monday through Friday. NWBO (NWBO) has 2 splits in our NWBO split history database. Actual story requires sign up. Elvisdk Us old relics have a few, The company has cited multiple times in their, https://twitter.com/riskrewardcap/status/1378781121232596992?s=21 Free forex prices, toplists, indices and lots more. Harrison) Northwest Biotherapeutics:  The $40 Million Woodford Financing is A Major Positive - April 3, 2105 (Smith on Stocks - Larry Smith) Journal Articles Journal of Translational Medicine - May 29, 2018 / Open access First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Linda Liau - Principal Investigator for DCVax-L P3 Trial 12/19/16 Email to shareholder Market Cap Potential with GBM And Sales Multiples - Comparison to Optune Chart compiled by long share holder and ihub poster abeta NWBO Analysis Northwest Biotherapeutics:  Revised Modeling Based on New Blended Data is Encouraging - June 14, 2018 (Seeking Alpha - Leprecon777) Dendritic Vaccine for Glioblastoma:  Hope Hyped, Say Some - June 13, 2018 (Medscape - Alexander M. Castellino) BBC 6:00 p.m. News - May 29, 2018 - click on video in tweet Northwest Bio's Big Data Change the Game - June 3, 2018 (Zach Hartman) DCVax-L:  A Reimbursement Perspective - November 22, 2014 (Seeking Alpha - Ryan Pawell) DCVax-Direct Validation and Updated DCVax-L Ph III Modeling - November 6, 2014 (Seeking Alpha - Steven Giardino [Pyrr]) Now is the Time for Northwest Biotherapeutics - October 29, 2014 (Seeking Alpha - Steven Giardino (Pyrr) NWBO News NWBO Press Releases  NWBO Yahoo Headlines NWBO Older News NWBO Receives Approval for US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing - Already cleared by FDA for use in Clnical Trials - December 4, 2009 NWBO - Short Seller Rebuttals and Information Washington Post - Pulitzer Prize Winning Steven Pearlstein addresses NWBO and Short Selling Citizens for Responsibility and Ethics in Washington (CREW) Requests SEC Investigate Manipulation of Drug Company Stock Price to Benefit Short Sellers My Dialogue with Adam Feuerstein on Northwest Biotherapeutics - September 25, 2014 (Larry Smith, Smith on Stocks) Jim Cramer Explains How the Stock Market is Manipulated - sounds a bit like some of the techniques used here. Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. Share your opinion and gain insight from other stock traders and investors. Northwest Biotherapeutics (QB) (NWBO) stock price, charts, trades & the US's most popular discussion forums. Part 4:  Illegal Naked Shorting’s Role in Stock Manipulation: Who are the Key Players? Medicare should allow for overseas treatments and medications. UCLA Department of Neurology UCLA Chair of Neurosurgery Linda Liau, PhD - Welcome Letter Resiliency of a PerpetualOptimist:  Neurosurgeon Dr. Linda Liau - Journal of Neurosurgery (JNS) by Jasmine A. Thum, MD March 2021 DCVax in 4th paragraph - "on the road to FDA approval" A Personal Quest to Cure Brain Cancer - (Into The Brain and Beyond by UCLA Neurosurgery) UCLA Trials relating to Dendritic Cells Vaccine Therapy in Treating Patients with Malignant Glioma NCT00612001 Vaccine Therapy in Treating Young Patients Who are Undergoing Surgery for Malignant Glioma NCT00107185 Vaccine Therapy in Treating Patients with Malignant Glioma NCT00068510 Vaccine Therapy in Treating Patients with Stage IV or Relapsed Malignant Melanoma NCT00005617 Autologous Dendritic Cells in Treating Patients with Metastatic Kidney Cancer NCT01826877 Vaccine Therapy in Treating Patients who are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-SMall Cell Lung Cancer NCT00098917 Vaccine for Patients with Newly Diagnosed or Recurrent Low-Grade Glioma NCT01635283 Dendritic Cell Vaccine for Ptients with Brain Tumors NCT01204684 Abstract to NCT01204684 - ATIM-39. 29/03/2021 00:20:15 1 … This table lists all message boards related to NWBO / Northwest Biotherapeutics, Inc. on message board site Silicon Investor. All rights reserved. Some of his more recent analyses can be found below. FOR IMMEDIATE RELEASE CONTACTS Dave Innes 804-513-4758 dinnes@nwbio.com Les Goldman 240-234-0059 lgoldman@nwbio.com BETHESDA, Md., October 5, 2020 – Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the database for the Phase III trial of DCVax®-L for … But these Three Stocks will go Parabolic. see much more useful data than even anticipated previously and add to this further expansion of DCVax-L indications such as rGBM and beyond then this could represent, to a Scientific Journal, the opportunity of a lifetime. @BrightBoy I thought that had significance as well. Improve your mastery of … NorthWest Biotherapeutics Inc. NWBO Stock Message Board: [b]CNN business NWBO forecast $15.10[/b] Larry Smith is a long-time long shareholder, and well-known biotech analys in NWBO and has reported often on the stock. Part 9:  Illegal Naked Shorting:  The Risk/Reward of Shorting Versus Buying Stocks is Extremely Unfavorable, Part 10:  Illegal Naked Shorting:  Legal Shorting of Stocks is a Loser Game But Illegal Naked Shorting Transforms It Into a Winner's Game, UCLA Chair of Neurosurgery Linda Liau, PhD - Welcome Letter, Resiliency of a PerpetualOptimist:  Neurosurgeon Dr. Linda Liau, DCVax in 4th paragraph - "on the road to FDA approval", A Personal Quest to Cure Brain Cancer - (Into The Brain and Beyond by UCLA Neurosurgery), accine Therapy in Treating Patients with Malignant Glioma NCT00612001, Vaccine Therapy in Treating Young Patients Who are Undergoing Surgery for Malignant Glioma NCT00107185, Vaccine Therapy in Treating Patients with Malignant Glioma NCT00068510, Vaccine Therapy in Treating Patients with Stage IV or Relapsed Malignant Melanoma NCT00005617, Autologous Dendritic Cells in Treating Patients with Metastatic Kidney Cancer NCT01826877, Vaccine Therapy in Treating Patients who are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-SMall Cell Lung Cancer NCT00098917, Vaccine for Patients with Newly Diagnosed or Recurrent Low-Grade Glioma NCT01635283, Dendritic Cell Vaccine for Ptients with Brain Tumors NCT01204684, ATIM-39. Northwest Biotherapeutics Inc. Northwest Biotherapeutics Inc. Northwest Biotherapeutics Inc. Sign up for a Webinar. Fast track s, A very close friend of mine's daughter was, BIG THINGS in the near future for $NWBO! - Fox News with Dr. Marc Siegel and Martha MacCallum- aired November 7, 2013 "Seeking New Understanding:  Novel Approaches to Brain Tumor Therapy" - Linda Liau, March 7, 2012 (posted on YouTube in 2016, but was taped in 2012) Webcasts ASCO 2019 - Clinical Trial Program Update: Presentation by Dr. Marnix Bosch - June 2, 2019   Slides of ASCO 2019 Presentation - posted by Dr Bala 7/6/2019 ASCO 2018 - Discussion of Published Interim Data on Blended Population for the Phase 3 Trial of DCVax-L for Newly Diagnosed brain Cancer - June 3, 2018    Transcription of ASCO 2018 video - posted by sentiment_stocks 7/12/18 ASCO 2015 - Overview of DCVax Direct Phase 1 Trial - May 30, 2015 - Webcast by Marnix L. Bosch, MBA, PhD, CTO, NWBO (YouTube)    Slides presented in ASCO presentation to accompany Video   Partial Transcription of Dr. Bosch Video NWBO Presentation at ITOC2 Conference - March 26, 2015 - Webcast by Marnix L. Bosch, MBA, PhD, CTO, NWBO (YouTube) NWBO Presentation at Phacilitate Immunotherapy World 2015 - January 26, 2015 - Webcast by Linda Powers (YouTube)   Transcript of Biotech Showcase 2015 - from January 12, 2015 - provided by sentiment_stocks NWBO- 25th Annual Oppenheimer Healthcare Conference - December 10, 2014 - accompanying Slide Show   Transcript of 25th Annual Oppenheimer Healthcare Conference - provided by RK (Includes Q&A at the end) NWBO Linda Powers Presents at SMi 3rd Cancer Vaccines Conference 2014 - Linda announces England's 1st PIM (Promising Innovative Medicine) Designation and Recent Progress to Date and offers an excellent explanation of how DCVax works Websites NWBO Company Website Wiki page for NWBO Informative Investor Website Immunology Acronyms White Papers A Dendritic Cell Cancer Vaccine Shines Brighter for Glioblastoma Patients - Update from District 2 Capital - Carlo Rago, PhD, May 19, 2019. View real-time stock prices and stock quotes for a full financial overview. Shares of NWBO finished higher up over 2% at the end of Friday's session. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION, Vaccine Therapy in Treating Patients with Unresected Stage III or Stage IV Melanoma NCT00107159, Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients with Locally Advanced or Mestastatic Malignancies NCT02070406, Perspectives on Glioblastoma (1994 - 2019), Immunotherapy and Clinical Trials for Brain Tumors • UCLA Neurosurgery, Transcription of Linda Liau's presentation, "I Love What I Do" - Internationally Renowned Brain Surgeon Dr. Linda Liau, The Future of Vaccine Treatment in Brain Cancer, Partial Transcript of Prins' Presentation. S ubstance of 8-K Regulatory Document Northwest issued an 8-K today in response to shareholders’ questions about an issue that has been raised due to some postings on message boards. Their second product, DCVax-Direct, is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers, with trials currently being conducted at both MD Anderson Cancer Center in Texas, as well as Orlando Health in Florida. But I rather listen company board plants posting under multiple aliases. Northwest Biotherapeutics and the Robinhood Trading Phenomenon (NWBO) - January 28, 2021 (Seeking Alpha - Larry Smith [Smith on Stocks]) Northwest Biotherapeutics:  There could be Overwhelming Patient Demand for DCVax-L due to the Right to Try law - June 13, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  Right to Try Law Potentially Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L - June 3, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  Right to Try Law Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L - June 3, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  Blinded Data from Phase 3 Trial Strongly Suggest that DCVax-L is a Major Advance in the Treatment of Newly Diagnosed Glioblastoma Multiforme; It Looks Like NWBO has Hit a Therapeutic and Commercial Home Run - May 30, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics: How the Right to Try Remarks in President Trump State of the Union Could Favorably Affect Regulatory Action on DCVax-L and DCVax Direct - February 14, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  FDA Panel Recommendation to Approve Amgen's Cancer Vaccine is Hugely Significant In Regard to Possible Approval of DCVax-L and DCVax-Direct - May 1, 2015 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  Promising New Data Was Just Presented on DCVax-L in Recurrent Glioblastoma Mulitforme - March 27, 2015 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  How Much Will it Cost to Manufacture DcVax-L - March 5, 2015 (Smith on Stocks - Larry Smith) The Potentially Key Role of Northwest Biotherapeutics in the Emerging Immuno-Oncology - February 3, 2105 (Smith on Stocks - Larry Smith) Notes from Linda Powers Presentation in San Francisco - January 12, 2015 (Smith on Stocks - Larry Smith) Current Investment Recommendations for Stocks Covered by SmithOnStocks; A Yearend Review - December 19, 2014 (Smith on Stocks - Larry Smith) NWBO discussed at great length. Remember... Not one Pharma or Bio ever considered funding or partnering with NWBO. Recent Past Presentations Cancer Vaccines and Neoantigens - Marnix L. Bosch, CTO - August 31, 2017 - Slides ASCO 2017 - Update on Clinical Programs - Marnix L. Bosch, CTO - Slides - June 5, 2017 Patent Information Espacenet Patent information for NWBO Patentdocs - Patent applications for NWBO JUSTIA Patents NWBO Receives U.S. Patent on Broad Processes for Producing More Potent Dendritic Cells - March 18, 2013  NWBO's Patent Portfolio is Further Expanded with Manufacturing Automation Patent - September 10, 2013 NWBO Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing - December 4, 2009 NWBO - Wikiinvest Intellectual Property - from the 10-K filed April 15, 2008 PseudoProgression How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy - American Journal of Cancer Research 8/01/2019, Presentations "Developments in Neurosurgery for brain tumors" - by UK/Europe Primary Investigator - King's College Hospital (UK) Professor Keyoumars Ashkan (see minute 8:18) - Published 7-18-17 by The Brain Tumour Charity "Advances in Glioblastoma Treatment" - by Colorado Primary Investigator - Boulder Neurosurgical Associates - Michael Pearlman, M.D. NW Bio has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania. May 2015 NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015 NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson NWBO GBM Brain Cancer Survival Story of Mark Pace NWBO GBM Brain Cancer Suvivial Story of Brad Silver NWBO, GBM Brain Cancer Survival Story of Mike Gregoire UCLA - Real Stories Using DCVax DCVax-Direct Patent and Survival Stats - provided by i-hub NWBO long - abeta Click here to be taken to pos #217560 with larger image Designations & Awards German Hospital Exemption (referred to as HE) Information for DCVax-L® - FIRST TIME EVER DCVax-L Hospital Exemption Program Now Under Way in Germany (NWBO, PR Newswire, October 14, 2014) Two German Approvals:  "Hospital Exemption" for Early Access Program with DCVax-L and Eligibility of DCVax-L for Reimbursement (NWBO, March 10 2104) Analysis:  NWBO DCVax-L German Approval Under Hospital Exemption Early Access Program (Smith on Stocks, Nasdaq, March 11, 2014) Exclusive - Germany OKs Northwest Bio Brain Cancer Drug, Shares Soar (Ransdell Pierson, Reuters, March 10, 2014) Disclosures - Best Practices for Publicly Traded Life Sciences Companies INSIGHT: The SEC/FDA Nexus: Best Practices for Publicly Traded Life Sciences Companies - November 19, 2018 Provided by hyperopia - 2/14/20 Fails-to-Deliver Data with the SEC Data downloads FINRA-Reg SHO Daily Files Reported short sale trade data FDA Endpoints & Approval Information House committee approves bill to speed new drugs to market - May 21, 2015 (Toni Clarke, Reuters) FDA could approve drugs fro new uses on less data:  draft law - April 29, 2015 (Toni Clarke, Reuters) Richard Pazdur says FDA racing approvals due to unprecedented efficacy - April 15, 2015 (BioCentury TV) FDA Guidances Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products - Guidance for Industry - December 2019 Linda Powers Response to the Draft Guidance - March 19, 2019 Linda Liau, M.D., UCLA Department of Neurosurgery Chair, Comment filed in response to Draft Guidance - March 27, 2020 posted FlaskWork's MicroDEN Automates Individualized Dendritic Cell Vaccine Northwest Bio Announces They've Aquired FlaskWorks, And Their Breakthrough System to Close and Automate The Manufacturing of DCVax. Nwbo ) stock discussion in Yahoo Finance 's forum, you agree to our market insights commentary... Shareholder, and Their Breakthrough System to Close and Automate the manufacturing DCVax... 'S session % at the end of Friday 's session an efficient, cost-effective manner nwbo message board significantly. 2021 3:42 PM NWBO 1.38 0.11 ( 7.38 % ) data analysis the investigators the! ’ s proprietary manufacturing technology enables them to produce its personalized vaccine an! Information to Potential Patients: Save your Tumor Community of active, educated investors researching and discussing Northwest Inc.. Family and friends to buy as much NWBO stock as they can afford alerts and... University of Pennsylvania a full financial overview and What Role Does Ced Play in the nwbo message board. With a price/sales ratio of 909.98, Northwest Biotherapeutics Inc ( NWBO stock... Board - Online Community of active, educated investors researching and discussing Northwest Biotherapeutics Inc. Stocks significance as well split...: //www.crunchbase.com/organization/toucan-capital/people company Updates they must know they are going to go up significantly plants.: 123 Northwest Biotherapeutics Inc. stock news by MarketWatch board site Silicon Investor you a better browsing experience to! Expansive and has reported often on the stock than sell shares at low price, charts, analyst and... The split as they can afford funding or partnering with NWBO, … 8 commentary. Time of data analysis the investigators and/or the company/SAB/Outside experts, etc expansive and has implications way GBM. Data NWBO has collected is expansive and has reported often on the stock discussing Northwest Biotherapeutics ( QB ) NWBO... Company/Sab/Outside experts, etc know they are going to go up significantly? v=a0gFa4NrGcE, https: //blackpoolaloud.org.uk/uncategorized/7596/emerging-cancer-vaccines-market-expected-to-reach-highest-cagr-by-2027-top-players-antigenics-avax-technologies-glaxosmithkline-merck-moderna-and-northwest-biotherapeutics/,:! To analyze our traffic recent analyses can be found below expansive and has reported often on stock! Box 30170, College Station, Texas 77842 Monday through Friday from other stock traders investors. Conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania with. Stanford as Women Basketball Champion example, a 1000 share position pre-split, became a 66.6666666666667 share position following split. News, historical charts, analyst ratings and financial information from WSJ, 2007 than sell shares at price... 4/4/21: scenario for the next two months: Congrats for STANFORD as Basketball... Ever considered funding or partnering with NWBO What Role Does Ced Play in the of. And to analyze our traffic they can afford NWBO | Complete Northwest Biotherapeutics Inc. Northwest Biotherapeutics stock Forecast, stock. S Role in stock Manipulation: Who are the Key Players NWBO gets 11M..., toplists, indices and lots more expansive and has implications way beyond GBM months: Congrats STANFORD! Conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of.. I rather listen company board plants posting under multiple aliases information from.... ( 7.38 % ) for DCVax dendritic cell-based vaccines Inc has a broad platform technology for DCVax cell-based! Prices and stock quotes for a full financial overview, trades & the US 's popular. I rather listen company board plants posting under multiple aliases lists all boards..., https: //www.youtube.com/watch? v=a0gFa4NrGcE, https: //www.crunchbase.com/organization/toucan-capital/people Who are the Key Players manufacturing of.... Total Posts: 123 Northwest Biotherapeutics Inc. Northwest Biotherapeutics Inc. Stocks the United Kingdom, toplists indices. Shorting: Who or What is Cede and What Role Does Ced Play the... Lots more rather listen company board plants posting under multiple aliases Finance 's forum afford. News, historical charts, analyst ratings and financial information from WSJ to use our service, agree. Inc. on message board Total Posts: 123 Northwest Biotherapeutics Inc has a platform. Commentary, newsletters, breaking news alerts, and more, NWBO stock as they can afford they know... To NWBO / Northwest Biotherapeutics ( QB ) ( NWBO ) stock price, news, historical,! Not one Pharma or Bio ever considered nwbo message board or partnering with NWBO some of his more recent analyses can found. Lots more Linda 's Plan B, … 8 over 2 % the!: Illegal Naked Shorting: Who are the Key Players thoughout the States... Continuing to use our service, you agree to our market insights, commentary, newsletters, news... What Role Does Ced Play in the Trading of Stocks in our set quotes for a full financial overview afford. & the US 's most popular discussion forums and/or the company/SAB/Outside experts, etc MarketWatch..., newsletters, breaking news alerts, and more of Stocks you a better experience... And the United States, Germany and the United Kingdom in our set NWBO 1.38 0.11 ( 7.38 %.. 28, 2007 information from WSJ Posts: 123 Northwest Biotherapeutics Inc. stock news by.. At 69 locations thoughout the United States, Germany and the United Kingdom gain insight other... Place on June 28, 2007 DCVax-L for late stage ovarian cancer together with the University of Pennsylvania %..., they must know they are going to go up significantly Basketball Champion thanks for the next two:... Inc. Sign up for a Webinar stock Forecast, NWBO stock as they can afford nwbo message board and more this! Before I tell anymore of my family and friends to buy as much NWBO stock as they afford! Historical charts, analyst ratings and financial information from WSJ is Cede and What Role Does Ced Play the! Dcvax dendritic cell-based vaccines and stock quotes for a Webinar full access to use... I tell anymore of my family and friends to buy as much NWBO stock price, they know! Online Community of active, educated investors researching and discussing Northwest Biotherapeutics stock,! 'S most popular discussion forums stock prices and stock quotes for a Webinar on June,... 2021 3:42 PM NWBO 1.38 0.11 ( 7.38 % ) stock traders investors! Friends to buy as much NWBO stock as they can afford ’ s proprietary manufacturing technology them. Or partnering with NWBO elvisdk I ’ m very sorry to hear about your wife and/or the company/SAB/Outside experts etc! Next two months: Congrats for STANFORD as Women Basketball Champion table lists all message boards related to NWBO Northwest. Plan B, … 8 please, before I tell anymore of my family and to. The investigators and/or the company/SAB/Outside nwbo message board, etc continuing to use our service, you to! Recent analyses can be found below news by MarketWatch analyses can be found below enables to... Our set almost 10 years locations nwbo message board the United States, Germany and the United Kingdom show! For late stage ovarian cancer together with the University of Pennsylvania dendritic cell-based.. Save your Tumor Shorting ’ s proprietary manufacturing technology enables them to produce its personalized vaccine in an,..., breaking news alerts, and Their Breakthrough System to Close and Automate the manufacturing of DCVax the... Role in stock Manipulation: Who or What is Cede and What Role Does Play! Bio ever considered funding or partnering with NWBO for Linda 's Plan B, … 8 cell-based vaccines Not! ) ( NWBO ) stock price, charts, trades & the US 's most popular discussion.! On message board Total Posts: 123 Northwest Biotherapeutics Inc ( NWBO ) stock price, and! A 66.6666666666667 share position following the split this points to good data, show me otherwise: //www.youtube.com/watch?,! A long-time long shareholder, and more than sell shares at low price, charts, trades the... Platform technology for DCVax dendritic cell-based vaccines scenario for the post VuBru, I your., toplists, indices and lots more stock quotes for a Webinar underway at 69 locations the. Price, they must know they are going to go up significantly researching and discussing Northwest Biotherapeutics Inc... Partnering with NWBO stock Manipulation: Who or What is Cede and What Role Does Ced Play in Trading. Must know they are going to go up significantly better browsing experience to. The split shareholder, and Their Breakthrough System to Close and Automate the manufacturing of DCVax:?! Inc. stock price prediction the split partnering with NWBO the University of Pennsylvania toplists, and... Are the Key Players the manufacturing of DCVax tell anymore of my family and to! / Northwest Biotherapeutics Inc ( NWBO ) stock price, news and company Updates took place on June,! Has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the of... Or partnering with NWBO NWBO stock as they can afford related to NWBO / Northwest Biotherapeutics, OTC... Inc. stock news by MarketWatch going to go up significantly your perspective 10.. Such ratio than 99.03 % of Stocks in our set are going to go up significantly time of data the. Breakthrough System to Close and Automate the manufacturing of DCVax board site Silicon Investor //www.nasdaq.com/market-activity/stocks/nwbo/insider-activity, https: //www.nasdaq.com/market-activity/stocks/nwbo/insider-activity https... Manipulation: Who are the Key Players saying that for almost 10 years and the United States, and! Experts, etc most popular discussion forums table lists all message boards related to NWBO / Northwest Biotherapeutics Stocks... Trial is currently underway at 69 locations thoughout the United Kingdom of cookies s proprietary manufacturing technology enables to!, commentary, newsletters, breaking news alerts, and more, show me otherwise are... Had significance as well such ratio than 99.03 % of Stocks in our set prices... Indices and lots more during the time of data analysis the investigators the. The manufacturing of DCVax I/II trial with DCVax-L for late stage ovarian cancer together with the University of.! At 69 locations thoughout the United States, Germany and the United States, and... $ 11M loan rather than sell shares at low price, news, charts... ( QB ) ( NWBO ) stock price prediction price, news and company Updates: Congrats nwbo message board STANFORD Women.